Skip to main content

Table 2 Multivariate logistic regression modelling in patients with diabetes

From: The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin

Variable

Adjusted OR

95 % CI

P value

Clinical Success (mITT Population)

 End of Treatment

  Vasopressors at Baseline (Yes vs No)

0.4

(0.2, 1.1)

0.073

  Treatment (LZD vs. VAN)

2.8

(1.2, 6.8)

0.022

  Bacteremia (Yes vs No)

0.2

(0.1, 0.7)

0.009

  Combined MIC (vs. 0.5)

   1

1.5

(0.2, 9.1)

0.673

   2 or 4

0.4

(0.1, 3.2)

0.384

  Pneumonia Type

   HCAP vs. HAP

2.9

(0.6, 13.7)

0.176

   VAP vs. HAP

0.6

(0.2, 1.5)

0.239

   HCAP vs. VAP

5.2

(1.3, 21.6)

0.023

  Smoking Status

   Current vs. Non-Smoker

0.9

(0.3, 2.4)

0.774

   Ex vs. Non-Smoker

2.3

(0.8, 6.1)

0.105

 End of Study

  Vasopressors at Baseline

0.3

(0.1, 0.8)

0.019

  Race (vs White)

   Asian

4.9

(1.7, 13.6)

0.002

   Black

1.7

(0.7, 4.3)

0.281

   Other

1.1

(0.2, 5.5)

0.885

Day 28 Mortality (mITT population)

 Age (10 years)

1.4

(1.1, 1.9)

0.014

 Chronic Dialysis Care (Yes vs No)

5.9

(1.8, 19.6)

0.004

 Race (vs. White)

  Asian

0.1

(0.0, 0.5)

0.004

  Black

1.0

(0.4, 2.6)

0.987

  Other

0.8

(0.1, 3.9)

0.735

 Subject Type (vs. Medical)

  Surgical

1.0

(0.4, 2.2)

0.921

  Trauma

1.3

(0.4, 5.1)

0.665

 Bacteremia (Yes vs. No)

2.2

(0.8, 6.0)

0.115

 Pleural Effusion (Yes vs. No)

0.5

(0.2, 1.0)

0.040

  1. CI confidence interval, mITT modified intent-to-treat OR odds ratio